These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25459683)

  • 1. Guidelines for treatment of chronic primary angle-closure glaucoma.
    Muñoz-Negrete FJ; González-Martín-Moro J; Casas-Llera P; Urcelay-Segura JL; Rebolleda G; Ussa F; Güerri Monclús N; Méndez Hernández C; Moreno-Montañés J; Villegas Pérez MP; Pablo LE; García-Feijoó J
    Arch Soc Esp Oftalmol; 2015 Mar; 90(3):119-38. PubMed ID: 25459683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma.
    Li J; Lin X; Yu M
    Eur J Ophthalmol; 2015; 25(1):18-26. PubMed ID: 25044139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Primary Angle-Closure Glaucoma.
    Lai J; Choy BN; Shum JW
    Asia Pac J Ophthalmol (Phila); 2016; 5(1):59-62. PubMed ID: 26886121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial.
    Narayanaswamy A; Baskaran M; Perera SA; Nongpiur ME; Htoon HM; Tun TA; Wong TT; Goh D; Su DH; Chew PT; Ho CL; Aung T
    Ophthalmology; 2016 Mar; 123(3):514-21. PubMed ID: 26707418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
    Aung T; Chan YH; Chew PT;
    Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for angle-closure glaucoma: an evidence-based update.
    Saw SM; Gazzard G; Friedman DS
    Ophthalmology; 2003 Oct; 110(10):1869-78; quiz 1878-9, 1930. PubMed ID: 14522756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the Efficacy and Safety of Latanoprost Monotherapy in Patients With Angle-closure Glaucoma.
    Chen R; Yang K; Zheng Z; Ong ML; Wang NL; Zhan SY
    J Glaucoma; 2016 Mar; 25(3):e134-44. PubMed ID: 25383466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-ocular pressure fluctuation after cataract surgery in primary angle-closure glaucoma eyes medically controlled after laser iridotomy.
    Özyol P; Özyol E; Sül S; Baldemir E; Çavdar S
    Acta Ophthalmol; 2016 Nov; 94(7):e528-e533. PubMed ID: 27040022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
    Chen MJ; Chen YC; Chou CK; Hsu WM
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma.
    Chen MJ; Chen YC; Chou CK; Hsu WM
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):449-54. PubMed ID: 17238812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Singapore 5-fluorouracil trial: intraocular pressure outcomes at 8 years.
    Wong MH; Husain R; Ang BC; Gazzard G; Foster PJ; Htoon HM; Wong TT; Oen FT; Khaw PT; Seah SK; Aung T
    Ophthalmology; 2013 Jun; 120(6):1127-34. PubMed ID: 23466269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study.
    Jin X; Xue A; Zhao Y; Qin Q; Dong XD; Qu J
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1611-6. PubMed ID: 17437125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angle-closure glaucoma.
    Poostchi A; Nicholas S; Wells AP
    Am J Ophthalmol; 2010 Mar; 149(3):524-5; author reply 525. PubMed ID: 20172077
    [No Abstract]   [Full Text] [Related]  

  • 15. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angle-closure glaucoma.
    Shimmyo M
    Am J Ophthalmol; 2009 Oct; 148(4):623; author reply 623. PubMed ID: 19782799
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angle-closure glaucoma.
    Neuburger M; Böhringer D; Reinhard T; Jordan JF
    Am J Ophthalmol; 2010 Apr; 149(4):687-8; author reply 688. PubMed ID: 20346787
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of angle closure glaucoma.
    See JL; Aquino MC; Aduan J; Chew PT
    Indian J Ophthalmol; 2011 Jan; 59 Suppl(Suppl1):S82-7. PubMed ID: 21150039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal intraocular pressure fluctuation and associated risk factors in eyes with angle closure.
    Baskaran M; Kumar RS; Govindasamy CV; Htoon HM; Wong CY; Perera SA; Wong TT; Aung T
    Ophthalmology; 2009 Dec; 116(12):2300-4. PubMed ID: 19850348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
    Novak-Laus K; Masnec-Paskvalin S; Korsić J; Iveković R; Zorić-Geber M; Mandić Z
    Acta Med Croatica; 2006; 60(2):113-6. PubMed ID: 16848200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma.
    Sihota R; Angmo D; Ramaswamy D; Dada T
    Indian J Ophthalmol; 2018 Apr; 66(4):495-505. PubMed ID: 29582808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.